Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

What's In Store For Mettler-Toledo's (MTD) Q4 Earnings?

Published 02/04/2020, 07:09 AM
Updated 07/09/2023, 06:31 AM

Mettler-Toledo International, Inc. (NYSE:MTD) is set to report fourth-quarter 2019 results on Feb 6.

The company topped the Zacks Consensus Estimate in all the trailing four quarters, delivering average positive earnings surprise of 1.3%.

Q4 Estimates

For fourth-quarter 2019, Mettler-Toledo anticipates sales growth of 3% on a year-over-year basis in local currency. The Zacks Consensus Estimate for revenues is pegged at $840.2 million, indicating growth of 2.7% from the year-ago reported figure.

Adjusted earnings are anticipated in the range of $7.66-$7.71 per share, suggesting 12-13%year-over-year growth. The Zacks Consensus Estimate for earnings is currently pegged at $7.69 per share, indicating growth of 12.3% from the year-ago quarter.

Mettler-Toledo International, Inc. Price and EPS Surprise

Performance in the Last Reported Quarter

In the last reported quarter, Mettler-Toledo came up with adjusted earnings of $5.77 per share, which increased 13% on a year-over-year basis. Moreover, the figure outpaced the Zacks Consensus Estimate by 1.1%.

In addition, net sales of $753.9 million were inline with the Zacks Consensus Estimate. The figure was up 3% year over year.

Let’s see how things have shaped up for this announcement.

Key Factors to Consider

Mettler-Toledo’s strong product pipeline — which includes robust analytical instruments and balances — is expected to have driven sales in the fourth quarter. Additionally, positive contributions from strategic acquisitions are likely to have aided its fourth-quarter performance.

The company’s Laboratory and Industrial segments are expected to have performed well in the quarter under review due to favorable market demand conditions.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Laboratory Instruments: The company’s investments in product portfolio expansion, field force, Spinnaker sales and marketing programs are likely to have driven sales growth in this segment. Further, growing R&D activities are anticipated to have negatively impacted the segment’s fourth-quarter performance.

The Zacks Consensus Estimate for sales in the Laboratory segment is pegged at $452 million.

Industrial Instruments: Mettler-Toledo’s solid momentum across core industrial business is likely to have driven the segment’s sales in the fourth quarter. However, softness in the company’s product inspection business owing to sluggishness in Europe is likely to get reflected on the segment’s fourth-quarter performance.

Notably, the Zacks Consensus Estimate for sales in the Industrial segment is pegged at $350 million.

Retail: This segment is comprised of the food retail business. However, weak momentum in this business is likely to have affected the company’s top line in the fourth quarter.

The Zacks Consensus Estimate for fourth-quarter sales in the Retail segment is $47.5 million.

Tariff imposition as a result of the U.S.-China trade war is likely to have impacted the company’s export-import activities in China in the fourth quarter. This is expected to get reflected on the company’s fourth-quarter results.

Also, currency headwinds might affect its fourth-quarter results.

What Our Model Says

Our proven model does not conclusively predict an earnings beat for Mettler-Toledo this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Mettler-Toledo currently has a Zacks Rank #3 and an Earnings ESP of 0.00%.

Stocks That Warrant a Look

Here are a few stocks worth considering as our model shows that these have the right combination of elements to deliver an earnings beat in the upcoming releases.

Five9, Inc. (NASDAQ:FIVN) has an Earnings ESP of +1.02% and a Zacks Rank of 2.

AMETEK, Inc. (NYSE:AME) has an Earnings ESP of +0.14% and a Zacks Rank #3.

Applied Optoelectronics, Inc. (NASDAQ:AAOI) has an Earnings ESP of +8.12% and a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.7% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>



Five9, Inc. (FIVN): Free Stock Analysis Report

Applied Optoelectronics, Inc. (AAOI): Free Stock Analysis Report

Mettler-Toledo International, Inc. (MTD): Free Stock Analysis Report

AMETEK, Inc. (AME): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.